Tatva Chintan Pharma Chem Ltd 2022 AR2
The report highlights Tatva Chintan Pharma Chem Limited's financial and operational performance for the fiscal year 2021-22. The company achieved a milestone by crossing the revenue mark of INR 400 Crore and PBT of more than INR 100 Crore. It successfully completed its Initial Public Offer (IPO) and listed on Indian stock exchanges in July 2021. On the sustainability front, the company converted its Ankleshwar manufacturing facility into a zero liquid effluent discharge facility and actively deploys green chemistry processes like electrolysis to minimize waste.
Company: Tatva Chintan Pharma Chem Ltd
Sector: Materials
Country: India
Year: 2022
Type: AR2
Pages: 256
Tatva Chintan Pharma Chem Ltd
Annual Report
The report highlights Tatva Chintan Pharma Chem Limited's financial and operational performance for the fiscal year 2021-22. The company achieved a milestone by crossing the revenue mark of INR 400 Crore and PBT of more than INR 100 Crore. It successfully completed its Initial Public Offer (IPO) and listed on Indian stock exchanges in July 2021. On the sustainability front, the company converted its Ankleshwar manufacturing facility into a zero liquid effluent discharge facility and actively deploys green chemistry processes like electrolysis to minimize waste.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Published
Aug 23, 2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees